Evaluation of the digital rectal examination as a screening test for prostate cancer FH Schröder, AB Kruger, J Rietbergen, R Kranse, P Maas, ... Journal of the National Cancer Institute 90 (23), 1817-1823, 1998 | 507 | 1998 |
Prostate cancer detection at low prostate specific antigen FH Schröder, I Van Der Cruijsen-Koeter, HJ De Koning, AN Vis, ... The Journal of urology 163 (3), 806-812, 2000 | 465 | 2000 |
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ... The Journal of urology 185 (1), 121-125, 2011 | 299 | 2011 |
Guidelines for processing and reporting of prostatic needle biopsies TH Van der Kwast, C Lopes, C Santonja, CG Pihl, I Neetens, ... Journal of clinical pathology 56 (5), 336-340, 2003 | 163 | 2003 |
The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study JBW RIETBERGEN, RF HOEDEMAEKER, AEB KRUGER, WIMJ KIRKELS, ... The Journal of urology 161 (4), 1192-1198, 1999 | 161 | 1999 |
Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer≤ 70 years CHM Leenen, MGF van Lier, HC van Doorn, ME van Leerdam, SG Kooi, ... Gynecologic oncology 125 (2), 414-420, 2012 | 155 | 2012 |
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)–Section Rotterdam: a comparison of two rounds of screening R Postma, FH Schröder, GJLH van Leenders, RF Hoedemaeker, AN Vis, ... European urology 52 (1), 89-97, 2007 | 153 | 2007 |
The European randomized study of screening for prostate cancer (ERSPC) FH Schröder, CH Bangma British Journal of Urology 79 (S1), 68-71, 1997 | 132* | 1997 |
Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy AN Vis, MO Boerma, S Ciatto, RF Hoedemaeker, FH Schröder, ... Urology 56 (4), 617-621, 2000 | 107 | 2000 |
Evaluation of prostate needle biopsies in a population‐based screening study: the impact of borderline lesions RF Hoedemaeker, R Kranse, JBW Rietbergen, AE Boeken Kruger, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 96 | 1999 |
Histopathological prostate cancer characteristics at radical prostatectomy after population based screening RF HOEDEMAEKER, JBW RIETBERGEN, R KRANSE, FH SCHRÖDER, ... The Journal of urology 164 (2), 411-415, 2000 | 94 | 2000 |
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features JC Alers, PJ Krijtenburg, AN Vis, RF Hoedemaeker, MF Wildhagen, ... The American journal of pathology 158 (2), 399-406, 2001 | 91 | 2001 |
Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ... European urology 57 (5), 821-829, 2010 | 90 | 2010 |
Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer JBW RIETBERGEN, AE BOEKEN KRUGER, RF HOEDEMAEKER, ... The Journal of urology 160 (6 Part 1), 2121-2125, 1998 | 87 | 1998 |
Pathologic features of prostate cancer found at population-based screening with a four-year interval RF Hoedemaeker, TH van der Kwast, R Boer, HJ de Koning, M Roobol, ... Journal of the National Cancer Institute 93 (15), 1153-1158, 2001 | 83 | 2001 |
Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancer RF Hoedemaeker, JBW Rietbergen, R Kranse, TH van der Kwast, ... World journal of urology 15, 339-345, 1997 | 76 | 1997 |
Staging prostate cancer RF Hoedemaeker, AN Vis, TH Van Der Kwast Microscopy research and technique 51 (5), 423-429, 2000 | 71 | 2000 |
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0–3.9 ng/ml) AN Vis, RF Hoedemaeker, M Roobol, TH Van Der Kwast, FH Schröder The Prostate 47 (4), 252-261, 2001 | 66 | 2001 |
Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70 years of age A Goverde, MCW Spaander, HC van Doorn, HJ Dubbink, ... Gynecologic oncology 143 (3), 453-459, 2016 | 51 | 2016 |
Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors H van Dekken, JC Alers, IAAJ Damen, KJ Vissers, PJ Krijtenburg, ... Laboratory investigation 83 (6), 789-796, 2003 | 50 | 2003 |